Susquehanna International Group, LLP Entera Bio Ltd. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Entera Bio Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 38,399 shares of ENTX stock, worth $89,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,399
Previous 20,658
85.88%
Holding current value
$89,085
Previous $39,000
102.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ENTX
# of Institutions
18Shares Held
7.52MCall Options Held
24.5KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$13.6 Million7.89% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY632KShares$1.47 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT414KShares$959,8580.13% of portfolio
-
Northern Trust Corp Chicago, IL212KShares$492,9600.0% of portfolio
-
Perigon Wealth Management, LLC San Francisco, CA146KShares$338,3550.01% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $66.8M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...